GlaxoSmithKline's Breast Cancer Drug Tykerb Gets FDA Approval - Trading Markets
March 13, 2007| GlaxoSmithKline's Breast Cancer Drug Tykerb Gets FDA Approval Trading Markets, CA - The company's bipolar disorder drug Lamictal and migraine medication Imitrex are expected to go off patent in 2008. The company also noted that Tykerb would ... |
Best-Selling Author Reveals Behind-the-Scenes Look at Seven ... - PR-Inside.com (Pressemitteilung)
March 13, 2007| Best-Selling Author Reveals Behind-the-Scenes Look at Seven ... PR-Inside.com (Pressemitteilung), Austria - Remicade: Johnson & Johnson's revolutionary biomedicine for the treatment of Crohn's disease, rheumatoid arthritis, and other immune mediated inflammatory ... |
Best-Selling Author Reveals Behind-the-Scenes Look at Seven ... - PR Newswire (press release)
March 13, 2007| Best-Selling Author Reveals Behind-the-Scenes Look at Seven ... PR Newswire (press release), NY - Remicade: Johnson & Johnson's revolutionary biomedicine for the treatment of Crohn's disease, rheumatoid arthritis, and other immune mediated inflammatory ... |